© Copyright Nostre Net
Market Synopsis:
The fertility
drug and surgery market share is expected to reach USD 2.21 billion by 2030
at 9.50% CAGR during the forecast period 2022-2030.The rates of infertility are
getting higher, which has encouraged massive investments in the research &
development of effective drugs and surgeries. Market Research Future (MRFR) has
highlighted in its latest analysis that the global fertility drug and surgery
market is projected to expand at a CAGR of 9.8% during the projection period of
2018 to 2023.
Infertility diseases affect both men and women. Treatments
have been developed for both the genders and drug research is expected to
constantly drive the expansion of the fertility drug and surgery market over
the next couple of years. In addition, rising working population of women has
led to increased cases of late pregnancies. This, in turn, is prognosticated to
boost the revenue creation of the fertility drug and surgery market over the
next couple of years.
Obesity is also a significant factor driving the growth of
the market. Increasing burden of obesity has led to an exponential increase in
the prevalence of infertility. It is projected to catapult the global fertility
drug and surgery market on an upward trajectory over the forecast period. Other
factors such as increasing disposable income, rising healthcare expenditure,
etc. are poised to influence the market positively. However, on the flip side,
factors such as high treatment cost and complications associated with surgeries
is anticipated to restrict market growth over the next few years.
Market Segmentation:
Based on the underlying cause, the global fertility
drug and surgery market outlook has been segmented into male and female.
By drug, the fertility drug and surgery market has been
segmented into letrozole, Serophene, clomiphene citrate, hormone treatment,
gonadotrophins estrogen receptor modulators, aromatase inhibitors, dopamine
agonists, metformin hydrochloride, and others.
Depending on the procedures, the global fertility drug and
surgery market has been segmented into laparoscopy and robotic laparoscopy,
hysteroscopy, laparotomy/open surgery, varicocelectomy, vasectomy reversal
(vasovasostomy or vasoepididymostomy), egg retrieval, sperm retrieval
(epididymal aspiration).
Based on end-user, the fertility drug and surgery market has
been segmented into hospitals, clinical research institutes, fertility clinics,
and others.
Regional Analysis:
A detailed geographical analysis of the global fertility
drug and surgery market has been included in this MRFR report which covers four
major regions – Americas, Asia Pacific, Europe, and the Middle East &
Africa (MEA). Americas is likely to lead the expansion of the market on account
of the increasing rate of infertility in the region. Rising prevalence of
obesity and increasing cases of delayed pregnancies are anticipated to catapult
the global fertility drug and surgery market on upward trajectory in the years
to come. Europe held the second leading position in 2017. It has been studied
in this report that the riding prevalence of sexually transmitted diseases is
responsible for increasing infertility rate in the region. On the other hand,
Asia Pacific fertility drug and surgery market is poised to exhibit immense
developments. Factors such as rising awareness, availability of healthcare
services, etc. are projected to boost revenue growth of the fertility drug and
surgery market in the region over the next few years.
Competitive Dashboard:
The key players participating in the landscape of the global
fertility drug and surgery market are Eli Lilly, Baxter Healthcare Corporation,
Ferring Pharmaceuticals, Inc., Merck & Co. Pharmaceutical Company, Noven
Pharmaceuticalorganon, Inc., Janssen Pharmaceuticals Inc., Personal Products
Company, Pfizer, Inc., Procter & Gamble Pharmaceuticals, and Emd Serono,
Inc. Growth strategies are expected to e executed by these players that are
poised to boost revenue creation in the market over the next couple of years.
Few of these strategies are mergers & acquisitions, collaborations,
partnerships, etc. Investments are also anticipated to be injected in the
future trajectory of the fertility drug and surgery market for gaining edge
over competitors.
Market Insights
The global dental CAM milling market is highly modest.
Market Research Future Reports published its latest reports on global The
Dental CAM Milling Machine Market is expected to reach USD 1,987.29 Million by
2030 at 9.30% CAGR during the forecast period 2022-2030. The market is at
a position to sustain its intense competition and introducing many
opportunities in the future timeline. To be at the same pace of growth and
market position, the key players are continually executing various strategies
such as mergers, acquisitions, partnerships, etc. to make the market rise high
and garner tremendous valuation in the coming years.
Global Dental CAM Milling Market: Drivers & Trends
The main factors responsible for the growth of global dental
cam milling machine market trends are accounted as high adoption of CAD/CAM
systems in the dentistry, that resulted in the increased usage of CAM milling
machines, growing ability to process different dental materials such as
zirconia, acrylic, wax, metal and others with high accuracy and precision. With
that, more factors supported behind the growth of the market, which is
accounted to be the growth of dental service organizations, development of new
dental restorative materials, patient-customized treatment approach, and
increasing cosmetic dentistry treatments.
Furthermore, the rise of numerous dental disorder cases,
increase of elderly population and surge in dental disorders that lead to tooth
deformations and technological innovation in dentistry are the factors that are
catering to the global dental milling machines market substantially. Besides,
more factors such as a surge in preference for corrective dental surgeries is
expected to augment the global dental milling machines market in the next few
years.
Dental CAM Milling Market Segmentation
According to the reports published by MRFR, the global
dental milling machines market has been segmented by type, application, and
end-user.
By the mode of type, the market includes ilab scale milling
machines and office scale milling machines.
By the node of application, the market includes crowns,
dentures, bridges, veneers, and inlays / onlays.
By the mode of end-user, the market has been categorized as
a dental laboratory, dental clinic, and research/academic institutes.
Regional Outlook
On a geographical note, the global dental
milling machines market report has covered the main regions of Europe,
North America, Asia Pacific, and the Middle East & Africa.
Among these, Europe has recorded and garnered the largest
share of the market owing to the early adoption of novel technologies in this
region. The newly advanced technology and dental hygiene witnessed in the
region are likely to boost the extension of the dental CAM milling machine
market in the next couple of years.
Whereas, North America is at the second position of the
global dental CAM milling machine market during the forecast period. Factors
such as the rising burden of dental disorders have projected to lead the growth
of the market in the region. Also, the emphasis of the healthcare providers
towards the progress of dental care services is probable to favor the growth of
the dental CAM milling machine market in the region at a rapid pace.
Lastly, the Asia Pacific region is a highly lucrative market
and is forecasted to record the highest CAGR over the forecasted period. The
rising population of older adults in countries of Asia Pacific is likely to
fuel demand for dental CAM milling machine along with the variations in the
food culture and lifestyle have been prone to boost the growth of the market
across the review period.
Key Players
Market Research Future Reports have sorted some of the key
players in this market are, they are Axsys Incorporated, B&D Dental
Technologies, DATRON AG, Dentsply Sirona, KaVo Dental GmbH, Planmeca OY,
Straumann, and Yenadent Ltd.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Analysis
The Cervical
Fusion market trends is anticipated to reach USD 8.10 Billion by 2030 at
3.90% CAGR during the forecast period 2022-2030.The market was valued at USD
1,938.15 million in 2021. Cervical fusion, simply put, is a surgery which helps
in joining selected bones in the cervical spine (neck). This surgery is
generally needed when the discs between each vertebra and the cervical
vertebrae get damaged due to chronic wear-and-tear or an injury. There are
different methods to perform a cervical fusion surgery such as using an
artificial graft made of metals or other polymers or inserting a bone graft for
natural bone regrowth.
Various factors are propelling the cervical fusion market
growth. These factors, as stated by the latest MRFR report, include increasing
prevalence of rheumatoid arthritis and osteoarthritis, growing aging
population, advent of cervical surgery techniques that are technologically
advanced, increasing incidences of cervical disorders, growing cases of cancer
and extensive research and development activities to diagnose and treat cancer,
and increasing funds for healthcare by government organizations.
On the flip side, the high price of treatments,
complications related to the cervical surgery, and the high price of the
diagnostic procedure are factors that may deter the cervical fusion market
growth over the forecast period.
Market Segmentation
The MRFR report provides a complete segmental analysis of
the cervical fusion market report on the basis of end user, surgery, type, and
fusion type.
Based on fusion type, the cervical fusion market is
segmented into posterior fusion, anterior cervical fusion, anterior interbody
fusion, and others. The interbody cervical fusion segment is again segmented
into bone interbody cervical fusion, non-bone interbody cervical fusion, and
others.
Based on type, the cervical fusion market is segmented into
polymeric type, metal type, and others.
Based on surgery, the cervical fusion market is segmented
into open spine surgery, minimally invasive spine surgery, and others.
Based on end user, the cervical fusion market is segmented
into neurology clinics, multispecialty hospitals, orthopedic clinics, and
others.
Regional Analysis
By region, the cervical
fusion market report covers the latest trends and growth opportunities
across Europe, the Americas, the Asia Pacific, and the Middle East and Africa.
Of these, the Americas will lead the market over the forecast period. This is
on account of increasing awareness about preventive care treatments to prevent
spinal deformities and increasing incidences of spinal deformities amongst the
older population.
The cervical fusion market in Europe is predicted to have
the second-largest share in the market over the forecast period. This is on
account of growing incidences of osteoarthritis and rheumatoid arthritis and
rising geriatric population.
The cervical fusion market in the APAC region is predicted
to grow at the fastest pace over the forecast period. This is owing to rapid
expansions by leading players for market development and the growing adoption
of cervical fusion surgeries. Japan is the chief contributor in this region
owing to the remarkable rise in the adoption of cervical fusion surgeries due
to presence of high aging population.
The cervical fusion market in the Middle East and Africa is
predicted to have steady growth during the forecast period. This is on account
of the rising emphasis on R&D activities in the healthcare sector and
extensive growth of healthcare infrastructure.
Key Players
Leading players profiled in the cervical fusion market
report include Shanghai Microport Orthopedics (China), Medacta (US), BAUMER
(Switzerland), Medicrea Technologies UK Ltd (UK), B. Braun Melsungen AG
(Germany), ArthroCare Corporation (US), Exactech, Inc. (US), RTI Surgical, Inc.
(US), AMEDICA Corporation (US), LDR Holding Corporation (US), Integra
LifeSciences Corporation (US), K2M, Inc. (US), Pioneer Surgical Technology
Spine (US), Alphatec Spine, Inc. (US), Zimmer Holdings, Inc. (US), Biomet, Inc.
(US), Orthofix Holdings, Inc. (US), Globus Medical Inc. (US), NuVasive, Inc.
(US), Stryker Corporation (US), Synthes, Inc. (US), DePuy Spine, Inc. (US), and
Medtronic, Inc. (US).
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
As per the latest published report by Market Research Future
(MRFR), the global forensic swab market is expected to grow at a decent pace in
the forthcoming years of the forecast period. The Forensic
Swab Market trends was valued USD 3630.47 million in 2021 and is expected
to reach USD 6,072.90 million by 2030 at 5.7% CAGR during the forecast period
2022-2030.
The usage of swabs in the forensic industry plays a critical
role in identifying and deciphering various genetic samples. Swabs are
considered as one of the most important tools for the collection of laboratory
samples. The growing adoption of Deoxyribonucleic acid (DNA) forensics and the
proliferating usage of laboratory services across hospitals as well as
independent agencies is anticipated to steer the forensic swab market towards
growth during the review period. Also, the global market for forensic swabs is
also forecasted to be accelerated by the favorable support from the government
and the rising levels of demand in the forthcoming years. Due to presence of
various notable and prominent players, the market is expected to garner notable
development in the coming years.
Market Segmentation
The global forensic swab market segmentation is based in
terms of type, end users, and type of swap shafts.
By type, the market comprises of foam, flocked, and cotton
tips. As per the last market study in 2017, the foam segment spearheaded with
the maximum share. The cotton swabs segment is expected to grow with the highest
growth rate during the forecast period.
By types of swab shaft, the market includes wood stick
shaft, polystyrene shaft, and others. As per the last conducted study of the
market, the polystyrene shaft segment held the top position in the global standings
in this category. The segment is also expected to garner the highest CAGR
during the assessment period.
By end-users, the market segments into hospitals, forensic
science laboratories, and others. The forensic science laboratories segment
held the leading position in this market category as per the last study. The
segment is further expected to continue its leading position in the forthcoming
years of the forecast period.
Regional Analysis
The global forensic
swab market report is regionally segmented into regions like the Americas,
Europe, Asia Pacific, and the Middle East and Africa.
The Americas hold the dominant share and shoulders a massive
portion of the global market. The Americas hold the largest share due to
factors like growing crime cases, increasing number of forensic labs, and
various samplings of blood. The region is expected to hold onto its dominant
position and lead the market standings in the forthcoming years. Additionally,
the expanding number of forensic labs and a rising number of microbiological
tests and hospitals also help drive the market in this region.
The European region hold the second largest share in the
market as per the last conducted study in 2017. The region is poised to grow in
the forthcoming years due to growth in the number of hospitals, research labs,
and the surging number of accident cases.
The Asia Pacific region is anticipated to grow at an annual
rate of 6.1% during the period between 2017 and 2023. The growth in this region
can be attributed to the growing commonness of numerous diseases, an expanding
number of forensic labs, and the imperative need for blood sampling. Lastly,
the Middle East and Africa region is anticipated to witness slow growth and
development due to limited exposure to forensic labs and lack of awareness
concerning forensic swabs.
Competitive Landscape
The global forensic swab market hosts a number of key and
prominent players who are modifying the competitive landscape in a positive
manner. This includes names such as Copan Italia S.p.A., Merck KGaA, Dickinson
and Company, SARSTEDT AG & Co. KG, Puritan Medical Products, Thermo Fisher
Scientific Inc., MWE, Becton, Sirchie, Luna, and MEDTECH Forensics.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Market Analysis
The plastic
surgery and integumentary system procedures market share is expected to
reach USD 4,456.6 Million by 2030 at 6.7% CAGR during the forecast period
2022-2030.Plastic surgery, simply put, is a medical process to restore,
correct, or alter skin on different parts of the body. It is generally
performed as a cosmetic or reconstructive procedure. On the other hand, the
integumentary system, simply put, is an organ framework that includes skin as
well as its extremities, which protects the body against various forms of
damages. It is mostly done for skin cancer, herpes, rabies, athlete’s foot,
rubella, psoriasis, acne, rash, sunburn, and infection.
Various factors are propelling the plastic surgery and
integumentary system procedures market growth. These factors as stated by the
latest Market Research Future report, include growing demand for procedures
especially cryosurgery, chemobrasion, and laser therapy, the influence of
social media, increasing media exposure, increasing rates of obese people,
advancements in technology in surgeries, increasing demand for retaining beauty
and youth, and increasing geriatric population.
On the flip side, the soaring cost of these procedures may
deter plastic surgery and integumentary system procedures market growth over
the forecast period.
Market Segmentation
The MRFR report offers a wide segmental analysis of the on
the basis of plastic surgery and integumentary system procedures market based
on end user, application, operating area, and procedure.
Based on the procedure, the plastic
surgery and integumentary system procedures market outlook is segmented
into skin tests, culture and sensitivity, incisional biopsy, excisional biopsy,
and prefilled syringe biopsy.
Based on the operating area, the plastic surgery and
integumentary system procedures market is segmented into skin, nose, breast,
subcutaneous tissue, and eyelids.
Based on application, the plastic surgery and integumentary
system procedures market is segmented into augmentation, skin cancer, athlete’s
foot, infection, autograft, allograft, and skin grafts.
Based on the end user, the plastic surgery and integumentary
system procedures market is segmented into research institutes, research
laboratories, and hospitals and clinics.
Regional Analysis
By region, the plastic surgery and integumentary system
procedures market report covers the latest trends and growth opportunities
across Europe, North America, the Asia Pacific, and the Middle East and Africa.
Of these, North America will dominate the market over the forecast period.
Factors pushing the growth of the plastic surgery and integumentary system
procedures market in the region include growing demand for cosmetic procedures,
highest expenditure by government sectors on the healthcare sector, consumers
changing lifestyle, growing senior population, growing awareness about surgical
procedures, and early adoption of new medical technologies.
The plastic surgery and integumentary system procedures
market in Europe is projected to have the second-largest share during the
forecast period. Factors pushing the growth of the plastic surgery and
integumentary system procedures market in the region include increasing rates
of surgeries owing to changing lifestyles, increasing research and development
activities, and increasing support and funding from the government to the
healthcare sector.
The plastic surgery and integumentary system procedures
market in the APAC region is projected to have a favorable growth during the
forecast period. Factors pushing the growth of the plastic surgery and
integumentary system procedures market in the region include the availability
of high-quality services, budding medical tourism, high access to technology,
and improving healthcare infrastructure.
The plastic surgery and integumentary system procedures
market in the MEA is projected to have a small share during the forecast period
owing to poor medical facilities, lack of technical knowledge, and
underdeveloped healthcare sector.
Key Players
Notable players profiled in the plastic surgery and
integumentary system procedures market report include Scivision Biotech Inc,
Integra Lifesciences, Sanofi, Valeant Pharmaceuticals, Allergan, Merz Pharma,
Galderma, Lumenis, Alma Lasers, Cynosure Inc., and Allergen Inc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Facial paralysis is a restriction of the
facial movement due to nerve damage. Facial nerve paralysis is characterized by
unilateral facial weakness. Some other symptoms include loss of taste,
hyperacusis, and decreased salivation and tear secretion.
Asia Pacific is the fastest growing market
for facial paralysis whose growth is attributed to the rising population and
increasing standard of living. Additionally, the increasing healthcare spending
and the improved standard of living are likely to drive the growth of the
market. India and China are the major contributors to the market growth due to
the rapid development of healthcare infrastructure in these regions and the
increasing demand for diagnostic services.
The global facial
paralysis market Trends is expected to register a CAGR of 6.5% during the
forecast period.
Key Players
Some of the key players in the facial
paralysis market are, Boston Scientific, BioControl Medical, Cerebomed,
Cyberonics, Astellas Pharma Inc., Sucampo Pharmaceuticals, Inc., and Novartis
AG, among others.
On the other hand, the Middle East and
Africa is expected to witness a gentle growth due to limited access to the
healthcare industry and affordability issues among the population. In the
Middle East, the growth of the market is driven by the increasing availability of
new and advanced diagnostic and treatment methods for various chronic diseases.
Segmentation
The global facial paralysis market is
segmented on the basis of treatment, diagnosis, type, and end-user.
On the basis of type, the market is
segmented into, Ramsay Hunt Syndrome, facial erythema, Bell’s Palsy, and Lyme
Disease.
On the basis of diagnosis, the market is
segmented into electromyography, computerized tomography, and magnetic
resonance imaging.
On the basis of treatment, the market
is segmented into medications, physical therapy, and surgery.
On the basis of medication, the
market is further sub-segmented into corticosteroids and antiviral drugs.
On the basis of end-user, the market is
segmented into hospitals and clinics, specialty centers, and research centers.
Regional Analysis
The Americas dominates the global facial
paralysis market Research Report owing to increasing cardiovascular
disorders, which eventually leads to the increasing patient population.
Additionally, increasing cardiovascular disorder rate is likely to enhance the
growth of facial paralysis in the North American region. According to the
American Heart Association, 31% of the deaths in the U.S. were due to
cardiovascular disorders. Similarly, in 2015, around USD 3.2 trillion were
spend in healthcare expenditure in the U.S according to the Center for Disease
Control and Prevention. Similarly, in 2015, 1.3% of the U.S. adults were
diagnosed with inflammation of facial nerves.
Europe accounts for the second largest
market due to increasing cardiovascular disorders and increasing infections.
Additionally, the increasing government support and improving healthcare infrastructure
along with increasing facial inflammations are driving the growth of the facial
paralysis market in Europe. For instance, Eurostat estimated that over 19.2% of
the population in Europe was aged 65 and above. This increasing older
population is likely to lead to the increasing patient population. These
factors are likely to drive the growth of the facial paralysis market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Gout
Market Overview and analysis By Type, By Treatment, By Diagnosis And By End-User Global Forecast Till 2030. The
gout market is anticipated to reach USD 4162.5 Million by 2030 at 11.75% CAGR
during the forecast period 2022-2030, which has been marked as the forecast
period by Market Research Future (MRFR) in the published report. The report
also includes several factors that can make sure the market would grow in the
coming years. Gout can be described as a type of arthritis, which is caused by
higher uric acid levels in the blood. The disease can be triggered by high
blood pressure, high cholesterol, and medications that can spike the presence
of uric acid in the blood. Obesity, diet containing a high amount of red meat,
consumption of alcohol and smoking can trigger symptoms of gout.
The market is getting better thrust from
factors like growing elderly population, transforming lifestyle that includes
more sedentary time, advents of better treatment facilities, and government
initiatives. However, lack of awareness can make this growth daunting in the
coming years.
Competitive Landscape:
The gout market is having a strong influx
of various new players who are giving tough competition to the existing market
bigshots. These players are launching their own types of market strategies to
make sure that they get good mileage from the market. Their strategic moves
often include mergers, new launches, acquisitions, investment, and others. MRFR
got these changes recorded in the report to get a closer view of how the market
is shaping up. These players are Savient Pharmaceuticals, Takeda Pharmaceutical
Company Ltd. Merck & Co. Inc., AstraZeneca plc, Astellas Pharma Inc.,
Ardelyx, Inc., and Novartis AG.
Regional Analysis:
The North American gout market has a
notable chance of making progress in the coming years. The regional market is
known for its high expenditure for the research and development sector, which
is triggering an increasing number of medicines that are getting launched every
year. Major countries inspiring changes are the US and Canada. The regional
number of smokers is also quite high, which, along with the high number of
geriatric population, can trigger the expansion of the gout market. High number
of obese people can also open up spaces for such diseases.
Europe’s market is the second-highest as
the regional awareness regarding gout-related problems is quite high. This is
getting fostered by the rising number of elderly people. Advanced treatment
facilities are also getting introduced owing to which a lot of people are
showing interest in getting their disease healed. This is also getting
bolstered by a rising amount of investment.
The Asia Pacific market is going to show
changes in the market as the growing awareness and the massive population is
expected to transform the market dynamics. The demographic conditions are also
going to play in favor of the market. Countries are launching extensive plans
for their healthcare sectors that can influence the gout market growth as well.
China would be the fastest-growing country. Transforming lifestyles are also
going to create space for market expansion.
The Middle East & Africa market may
suffer from the presence of poor economies, lack of awareness, and insufficient
backing from the technological setup. However, the scenario is changing in
countries like the UAE, Dubai, Saudi Arabia, Qatar, and others.
Segmentation:
The global gout
market research reports of MRFR suggests, can be studied on the basis of an
expert segmentation that includes end-user, treatment, type, and
diagnosis. The report focuses on achieving insights from the market and
that has initiated a detailed review of each segment.
By type, the report on the gout market can
be segmented into tophaceous gout and pseudogout. Both these segments are known
for their impact on the market and revenue-generation.
By treatment, the gout market report can be
segmented into medications and self-care. The medication segment includes
Probenecid, Allopurinol, Febuxostat, Diclofenac, Indomethacin, and Ibuprofen.
The self-care segment is getting acknowledged by patients across the world.
By diagnosis, the market report on the gout
industry can be segmented into blood tests, MRI, X-ray, ultrasound, urine test,
CT scan, and others. Growing demand for early diagnosis is expected to set up a
significant scope for these tests to fetch high income.
By the end-user, the market report on the
gout industry comprises specialty centers, hospitals, and homecare. The home
care segment is witnessing a surge as an increasing number of people are opting
for the self-care segment.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Mental health has come into focus due to
changing lifestyles of patients and unhealthy work hours. Mental health
software and devices utilizes the power of information technology to keep a
check on mental or behavioral disorders. The global mental health software and
devices market report by Market Research Future (MRFR) focuses on various
issues plaguing the market as well as efforts by manufacturers.
The mental
health software and devices market share is expected to reach USD 17.2
Billion by 2030 at 16.1% CAGR during the forecast period 2022-2030
Market Outlook
due to the rapid adoption of software by
mental health professionals. Change in health practices due to availability of
patient records and mental health history can lead to effective management of
patients. Collection and analysis of information, elimination of errors, rise
in patient income levels, and demand for effective solutions for management of pharmacies
are mental health are other drivers of the market.
Development of wearables, changing
attitudes of patients and doctors towards information technology, and pressure
on hospitals to reduce operational costs can drive the global mental health
software and devices market. Real-time monitoring of patient health and
provision of advice and medicines via telemedicine can bode well for the market
growth in the coming years.
Competition Outlook
Prominent mental health software vendors
and device manufacturers profiled in the report include Athena Health,
Mindlinc, Mentegram, WRS Health, Kareo, Nextgen Healthcare, ICANotes, Core
Solutions, InSync Healthcare Solutions, Compulink, Allscripts, Nuesoft
Technologies, NextStep Solutions, Valant, Credible Behavioral Health,
Welligent, Raintree Systems, Netsmart, Meditab Software, Orion Health, The Echo
Group, Sigmund Software, IBM, TheraNest, Advanced Data Systems, AdvancedMD,
Qualifacts, McKesson Corporation, iSalus Healthcare, and Cerner Corporation.
Regional Analysis
Region-wise, the global market comprises
North America, Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.
North America accounted for the largest
market led by the U.S. due to focus on mental health by governments. According
to the American Psychological Association in 2019, the number of young U.S.
citizens with an increase of mental health disorders has risen due to shift in
mood disorders. Other drivers include rapid adoption of technology and
development of healthcare infrastructure by governments.
Europe is the second largest region of the
market driven by large number of burnout cases and mental health issues of
employees. Governments in the region have developed a common platform for
collection of mental health issues and records of patients for implementation
of good policies as well as welfare schemes. On the other hand, the APAC region
is expected to exhibit the fastest growth rate during the forecast period due
to being driven by economies of China, India, and Japan. International brands
in the region are giving mental health insurance for preventing burnouts and
reducing stress in the workplace.
Segmentation Analysis
the global mental
health software and devices market insights is segmented on the basis of
solution, deployment, end users and regions.
By component, the market has been segmented
by software and devices. The software has been sub-segmented into web based and
standalone software.
By functionality, the market has been
segmented by clinical, administrative, financial and others. The clinical
segment has been categorized into tele-health, electronic health records
(EHRs), E-prescribing, clinical decision support, health management, and
others. The administrative has been sub segmented into information management,
scheduling, workforce management, and others.
The financial has been sub segmented into
accounting, revenue cycle management, business intelligence, and others.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Surgical devices are types of instruments
that are used for performing numerous forms of surgeries in accordance to the
complexity of the surgery like minimally invasive, open, or other types of
surgery. The General
Surgical Devices Market Share is anticipated to reach USD 15.1 Billion by
2030 at 8.60% CAGR during the forecast period 2022-2030.
As per the research conducted by Market
Research Future (MRFR), the market is identified to be influenced by numerous
factors. The high demand centered around disposable supplies like catheters,
syringes, and needles, the growing awareness concerning diseases being
transmitted through surgical forms of devices, and favorable government
regulations in ensuring or maintaining safety in surgical procedures are
expected to stimulate a positive demand for disposable products, thereby
pushing the overall general surgical devices market. An influx of global health
initiatives causing advancement in surgical procedures are expected to drive
the global general surgical devices market. However, factors like strict
government regulations in developing nations and improper reimbursement for
surgical devices can cause the market to falter in terms of growth.
Competitive Landscape
The global general surgical devices market
comprises of numerous players. A few of them identified in the report are 3M
Healthcare (U.S.), Johnson & Johnson Services, Inc. (U.S.), B. Braun
Melsungen AG (Germany), Grifols (Spain), SOFINA s.a (Biomérieux) (U.S.), Erbe
Elektromedizin GmbH (Germany), Integra LifeSciences (U.S.), Medtronic Plc.
(U.S.), Smith & Nephew (U.S.), Stryker Corporation (U.S.), Maquet Holding
B.V. & CO. KG. (Germany), CareFusion Corporation (U.S.), Becton, Dickinson
and Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Conmed Corporation
(U.S.), Accuray Incorporated (U.S), Boston Scientific Corporation (U.S.),
Ortho-Clinical Diagnostics, Inc. (U.S.), Intuitive Surgical Inc. (U.S.),
Siemens Healthcare GmbH (Germany), Cadence Inc. (U.S.), Thermo Fisher
Scientific, Inc. (U.S.), Virtual Incision Corporation (U.S.), Titan Medical
(Canada), Medrobotics Corporation (U.S.), TransEnterix Surgical (U.S.), Olympus
Corporations (U.S.), Verb Surgical (U.S.), Meere Company (U.S.), and others.
Market Segmentation
The global general
surgical devices market report segmentation is done on the basis of
application, type, product, and end-user.
By type, the market includes energy-based
and powered instrument, disposable surgical supplies, minimally invasive
surgery instruments, surgical instruments, medical robotics, open surgery
instrument, computer-assisted surgery devices, and others.
The disposable surgical supplies segment is
narrowed down into examination and surgical gloves, surgical non-woven, venous
access catheters, general surgery procedural kits, needles and syringes, and
others.
The surgical non-woven segment is broken
down into surgical drapes, disposable surgical masks, surgical caps, surgical
gowns, and others.
The open surgery instrument narrows down
into dilator, retractor, and catheters.
The energy-based and powered instrument is
divided into drill system and powered staplers.
The minimally invasive surgery instruments
segments into organ retractor and laparoscope.
The medical robotics and computer-assisted
surgery devices segment breaks down into adhesive prevention products and
others.
By product, the market includes
electrosurgical devices, trocars and access devices, handheld devices, wound
closure devices, laparoscopic devices, and others.
By application, the market comprises
thoracic surgery, ophthalmology, plastic surgery, orthopedic surgery,
cardiology, neurosurgery, audiology, into wound care, urology and gynecology
surgery, and others.
By end-user, the market includes research
centers, diagnostic centers, hospitals, academic institutes, clinics, and
others.
Regional Analysis
The global general surgical devices market
is geographically segmented across the following regions: Europe, America, Asia
Pacific, and the Middle East and Africa.
The Americas dominate the global market
with the highest share percentage and is expected to further maintain its
standings in the forthcoming years. This is due to the vast presence of key
players, a striking number of surgical procedures, favorable reimbursement
policies, and various initiatives undertaken by the government for providing
training sessions as well as access to advanced devices for physicians.
The Asia Pacific region is projected to
grow at the maximum pace during the forecast period owing to growing
investments alongside the regional expansion. The Middle East and Africa region
boasts the potential to emerge out as a big production hub for large-scale
development and medical devices. This is due to the low cost associated with
product development here in this region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Insights
The non-invasive nature of optical
coherence tomography (OCT) and its ability to generate a false-color depiction
of tissue structure has made the global market for OCT highly lucrative. OCT is
comparable to ultrasound imaging, with the principal difference that the
technology uses light instead of sound. Research & development of the
technology has led to efficient, fast and accurate OCT devices which have
branched out from ophthalmology to include medical applications in dermatology,
and cardiology among others, thus facilitating growth. Market Research Future's
report on the Optical
Coherence Tomography Market share to gain a valuation of USD 15.50
Billion by 2030 at 15.5% CAGR.
Prevalence of eye diseases and the rising
occurrence of cardiac conditions have motivated market growth. Rising demand
for OCT has led to R&D for technological advancements which in turn is
expected to increase market growth further. Presently, although there are many
applications for OCT devices, they are primarily used in ophthalmology, this
indicates unrealized potential yet to be explored which will likely push demand
for this technology in the coming years.
High costs associated with portable optical
coherence tomography may hamper growth. However, increasing use in various
applications, supportive government regulations and favorable reimbursements
are likely to mitigate this challenge to a great extent.
Regional Analysis
The Americas hold the largest share with
nearly 37% of the global market share. Increasing occurrence of diabetic
retinopathy and other eye diseases is one of the key factors driving the growth
of the market. Moreover, there is a strong presence of market leaders. MRFR as
predicted that region will reach an evaluation of approximately USD 558.34
million by 2023.
Europe follows the Americas lead and is
expected to maintain a strong second lead due to supportive government policies
and research & development carried out by private players is the primary
propeller for the growth of the OCT market over the forecast period. The region
is expected to closely follow the growth pattern of the Americas.
The Asia-Pacific region, is predicted to be
the fastest growing region with a CAGR of 9.4% during the forecast period. A
massive patient population in the region with a rising incidence of eye
diseases and diabetic retinopathy is expected to fuel rapid growth for the
region. International market leaders are trying to enter this region, and this
is likely to facilitate growth in the coming years further.
The Middle East & Africa are expected
to experience limited growth. This is primarily due to the passive development
in the African continent.
Market Segmentation
The optical
coherence tomography market outlook has been segmented by technology,
application, type of devices and region.
By technology, the market has been
segmented into spectral-domain OCT (SD-OCT), swept-source OCT, and others. The
SD-OCT segment is predicted to dominate with approximately 60% share of the
total market during the forecast period. Meanwhile, swept-source OCT is the
fastest growing segmented and is expected to grow at CAGR of 9.1% during the
review period.
By application, the market has been
segmented into cardiology, ophthalmology, dermatology, oncology, and others.
Ophthalmology has the most significant segment with over 53% of the market
share. However, dermatology is the fastest growing application segment and is
expected to grow at a considerable 9.3% CAGR during the forecast period.
By type of devices, the market has been
segmented into handheld OCT devices, tabletop OCT devices, catheter-based OCT
devices, and others.
By region, the market has been segmented
into the Americas, Europe, Asia Pacific and the Middle East and Africa.
Key Players
Market leaders have been featured in the
report to provide a comprehensive understanding of the competitive landscape.
Prominent players included in the report are Imalux Corporation, Optovue,
Michelson Diagnostics, Carl Zeiss AG, Alcon, Abbott Laboratories, Terumo
Corporation, KONINKLIJKE PHILIPS N.V, B. Braun Melsungen AG, Boston Scientific
Corporation, OPTOPOL Technology S.A, Heidelberg Engineering GmbH, Topcon
Corporation, NIDEK Co., Ltd, Novacam Technologies Inc, Thorlabs Inc., and Agfa
Healthcare
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.